课题基金 / 基金详情

Evaluation of the usefulness of ^<99m>Tc-MIBI scintigraphy and positron emission tomography to analyze the radiotherapeutic effects in breast cancer models

Evaluation of the usefulness of ^<99m>Tc-MIBI scintigraphy and positron emission tomography to analyze the radiotherapeutic effects in breast cancer models
评估^<99m>Tc-MIBI闪烁扫描和正电子发射断层扫描分析乳腺癌模型放射治疗效果的有效性
批准号:
11671145
负责人:
HARADA Yuko
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
放射治疗是原发性和转移性乳腺癌的主要治疗手段。本研究旨在探讨~(13)<99m>Tc-MIBI和脱氧葡萄糖(DG)在乳腺癌模型照射前后分布的差异。我们还研究了微血管密度和13 Tc-MIBI摄取之间的相关性<99m>。【材料与方法】采用<99m><14>小鼠乳腺癌细胞系FM 3A、MM 48和埃利希,用~(13)Tc-MIBI和~(13)C-DG制备小鼠乳腺癌移植模型的双示踪剂宏观放射自显影(ARG)图像。放射治疗效果通过测量肿瘤负荷、摄取和使用^ Tc-MIBI和^ F-FDG的ARG发现来监测<99m><18>,微血管密度通过免疫组织化学染色CD 34来定量,并与使用^ Tc-MIBI的ARG进行比较<99m>。[结果] 3种肿瘤的生长速度和放射敏感性不同,但~(13)<99m>Tc-MIBI摄取量与肿瘤生长速度无明显相关性。在<14><99m>所有肿瘤模型中,与^ C-DG相比,^ Tc-MIBI在癌细胞中积累更多,而在浸润的成纤维细胞和巨噬细胞中积累更少。肿瘤组织中的微血管密度与<99m>ARG上的13 Tc-MIBI摄取显著相关。[结论]<99m>~(13)Tc-MIBI在肿瘤细胞中有明显的蓄积作用,可作为评价放疗疗效的敏感指标。血管生成似乎增强了肿瘤中13 Tc-MIBI的积累<99m>。这些特征可能有利于使用13 Tc-MIBI进行肿瘤成像<99m>。
英文摘要
【Introduction】 Radiotherapy is a principal treatment in primary and metastatic breast cancer. The aim of this study was to investigate the difference of distribution of ^<99m>Tc-MIBI and deoxyglucose (DG) before and after irradiation in breast cancer models. We also investigated the correlation between microvessel density and ^<99m>Tc-MIBI uptake.【Materials and Methods】 Double-tracer macroautoradiography (ARG) images were prepared with ^<99m>Tc-MIBI and ^<14>C-DG in transplanted models using 3 mouse breast cancer cell lines (FM3A, MM48 and Ehrlich). The radiotherapeutic effects were monitored by measuring tumor burden, uptake and ARG finding using ^<99m>Tc-MIBI and ^<18>F-FDG.Microvessel density was quantified by immunohistochemical staining for CD34 and compared with ARG using ^<99m>Tc-MIBI.【Results】 Three tumors showed different growth rates and radiosensitivities, but ^<99m>Tc-MIBI uptake did not correlate significantly with the growth rates. Compared with ^<14>C-DG, ^<99m>Tc-MIBI accumulated more in cancer cells and less in infiltrating fibroblasts and macrophages in all tumor models. Microvessel density in tumor tissue correlated significantly with ^<99m>Tc-MIBI uptake on ARG.【Conclusion】 Accumulation of ^<99m>Tc-MIBI in cancer cells is preferential and can be used as a sensitive marker to examine the response of radiotherapy. Angiogenesis seems to enhance accumulation of ^<99m>Tc-MIBI in tumors. These characteristics may be favorable for tumor imaging using ^<99m>Tc-MIBI.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Hiromichi Ohira: "Comparison of introtumoral distribution of ^<99m>Tc-MIBI and deoxyglucose in mouse breast cancer models."J Nucl Med. 41. 1561-1568 (2000)
Hiromichi Ohira:“小鼠乳腺癌模型中^<99m>Tc-MIBI和脱氧葡萄糖的瘤内分布比较。”J Nucl Med。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hiromichi Chira: "Comparison of intratumoral distribution of ^<99m>Tc MIBI and deoxyglucose in mouse breast cancer models"J Nucl Met. 41. 1561-1568 (2000)
Hiromichi Chira:“小鼠乳腺癌模型中^<99m>Tc MIBI和脱氧葡萄糖的瘤内分布比较”J Nucl Met。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hiromichi Ohira: "Intra-tumoral accumulation of technetium -99m sestamibi deoxyglucose in mouse breast cancer models."CYRIC Annual Report. 145-151 (1998)
Hiromichi Ohira:“小鼠乳腺癌模型中锝-99m 司他米比脱氧葡萄糖的肿瘤内积累。”CYRIC 年度报告。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hiromichi Ohira: "Comparison of intratumoral distribution of ^<99m>Tc-MIBI and deoxyglucose in mouse breast cancer models"J Nucl Med. 41. 1561-1568 (2000)
Hiromichi Ohira:“小鼠乳腺癌模型中^<99m>Tc-MIBI和脱氧葡萄糖的瘤内分布的比较”J Nucl Med。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
国内基金
海外基金
间位芳纶(PMIA)短切纤维-涤纶(PET)浆粕复合纸的制备设备研发
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    许红伍
  • 依托单位:
基于18F-FAPI-04 PET/CT与增强CT的Suidan评分在卵巢癌减瘤术前评估中的价值比较研究
  • 批准号:
    2026JJ81876
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    戴嘉舜
  • 依托单位:
基于高灵敏度PET/CT的碳离子放疗剂量验证与疗效预测研究
PET分子影像评估肾癌碳酸酐酶9表达异质性及其对靶免联合治疗响应的预测作用与机制研究
  • 批准号:
    JCZRLH202600197
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位: